clock menu more-arrow no yes

Filed under:

A deal between Chelsea and Kai Havertz looks imminent

New, comments

It looks like another excellent player will be bolting the Bundesliga in favor of Chelsea as Bayer Leverkusen’s Kai Havertz is close to a lucrative deal with the London-based club.

FC Internazionale v Bayer 04 Leverkusen - UEFA Europa League Quarter Final Photo by Stuart Franklin/UEFA via Getty Images

With Bayern Munich crowned UEFA Champions League winners, the talent in the Bundesliga is certainly going to get more attention abroad. One club that already had its eyes wander over to Deutschland is Chelsea and the Blues mean business.

After plucking Christian Pulisic from Borussia Dortmund during the 2019 winter transfer window, Chelsea has been looking quite fondly at continental Europe. Earlier this summer, the Premier League club brought in former RB Leipzig star Timo Werner to bolster its attack, but Chelsea was not yet done with Germany.

Not by a long shot.

With one of Die Mannschaft’s most dangerous scorers already in tow, Chelsea is reportedly close to a deal with Bayer Leverkusen ace Kai Havertz, who is arguably Germany’s top overall prospect under the age of 22.

Sport Bild chief Christian Falk originally tweeted his report this morning and — if true — Bayer Leverkusen could stand to eventually earn €100 million should Havertz help Chelsea meet all of the performance-driven incentives contained within the deal:

Italian journalist Fabrizio Romano followed up later today with an confirmation of Falk’s report. Romano loses a style point or two for not just “quote-tweeting” Falk with “True,” but we’ll let him slide this time:

Chelsea’s squad planning with Werner and Havertz seems to indicate the club’s seriousness in returning to its past glory, but the London-based club is not stopping at raiding Germany. Chelsea will also reportedly add defender Thiago Silva from Paris Saint-Germain on a free transfer. The 35-year-old Champions League runner-up with reportedly sign a two-year deal with Chelsea.